Dyne Therapeutics, Inc. · NASDAQ:DYN
Friedl-Naderer Johanna sold 145 Dyne Therapeutics, Inc. shares (Form 4)
Traded Jun 16, 2026 · Filed Jun 17, 2026
On Jun 16, 2026, Friedl-Naderer Johanna (Chief Commercial Officer) sold 145 Dyne Therapeutics, Inc. shares at US$18.33 for US$2,658 under a trading plan, leaving 154,208 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 145 shares
- Price
- US$18.33
- Value
- US$2,658
- Holding after
- 154,208 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | Sale | 145 | US$18.33 | 154,208 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Friedl-Naderer Johanna
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Friedl-Naderer Johanna · Aug 17, 2026
- Form 4 · Friedl-Naderer Johanna · May 14, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026
- Form 4 · Cox John · Aug 17, 2026